Commonwealth Equity Services’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Commonwealth Equity Services’s Portfolio KERX Stock Details KERX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-10,684	Closed	-$36K	–	2885
2018 Q3	$36K	Sell	10,684 -250	-2%	-$901	﹤0.01%	2715
2018 Q2	$41K	Hold	10,934	–	–	﹤0.01%	2676
2018 Q1	$44K	Hold	10,934	–	–	﹤0.01%	2601
2017 Q4	$51K	Hold	10,934	–	–	﹤0.01%	2570
2017 Q3	$78K	Buy	10,934 +250	+2%	+$1.8K	﹤0.01%	2438
2017 Q2	$77K	Hold	10,684	–	–	﹤0.01%	2396
2017 Q1	$66K	Hold	10,684	–	–	﹤0.01%	2308
2016 Q4	$63K	Hold	10,684	–	–	﹤0.01%	2229
2016 Q3	$57K	Sell	10,684 -2,674	-20%	-$14.4K	﹤0.01%	2160
2016 Q2	$88K	Hold	13,358	–	–	﹤0.01%	2123
2016 Q1	$62K	Buy	13,358 +3,074	+30%	+$12.3K	﹤0.01%	2116
2015 Q4	$52K	Sell	10,284 -6,100	-37%	-$29K	﹤0.01%	2099
2015 Q3	$58K	Buy	+16,384	New	+$110K	﹤0.01%	2041

Commonwealth Equity Services's KERX Position: Q4 2018 in Review

Commonwealth Equity Services sold out of Keryx Biopharmaceuticals Inc (KERX) in Q4 2018, closing a stake of 10,684 shares — an estimated $36K sold.

Commonwealth Equity Services first reported a position in KERX in Q3 2015 and held it in 13 quarters. The position peaked at $88K in Q2 2016. 1 fund tracked by Wall St. Rank holds KERX as of Q4 2018.

Commonwealth Equity Services reported no remaining Keryx Biopharmaceuticals Inc position as of Q4 2018 after selling out during the quarter.
Commonwealth Equity Services sold 10,684 Keryx Biopharmaceuticals Inc shares in Q4 2018, an estimated $36K.
Commonwealth Equity Services first reported a position in Keryx Biopharmaceuticals Inc in Q3 2015 and held it in 13 quarters.
Commonwealth Equity Services's Keryx Biopharmaceuticals Inc position peaked at $88K in Q2 2016.
1 fund tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q4 2018.

Based on Commonwealth Equity Services's 13F filing for Q4 2018, filed 11 Feb 2019.